Tonghua Dongbao Pharmaceutical Co., Ltd.

Tonghua Dongbao Pharmaceutical Co., Ltd.verified

600867.SS

Price:

$8.41

Market Cap:

$16.44B

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Industry

Drug Manufacturers - General

IPO Date

1994-08-24

Stock Exchange

SHH

Ticker

600867.SS

The PE Ratio as of December 2025 (TTM) for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is 13.56

According to Tonghua Dongbao Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 13.56. This represents a change of -77.17% compared to the average of 59.40 of the last 4 quarters.

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Historical PE Ratio (quarterly & annually)

How has 600867.SS PE Ratio performed in the past?

The mean historical PE Ratio of Tonghua Dongbao Pharmaceutical Co., Ltd. over the last ten years is -12.97. The current 13.56 PE Ratio has changed -10551.27% with respect to the historical average. Over the past ten years (40 quarters), 600867.SS's PE Ratio was at its highest in in the December 2024 quarter at 165.28. The PE Ratio was at its lowest in in the June 2024 quarter at -9.43.

Quarterly (TTM)
Annual

Average

-12.97

Median

30.36

Minimum

-403.00

Maximum

52.61

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Tonghua Dongbao Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 60.50%

Maximum Annual PE Ratio = 52.61

Minimum Annual Increase = -2295.48%

Minimum Annual PE Ratio = -403.00

Quarterly (TTM)
Annual
YearPE RatioChange
2024-403.00-2295.48%
202318.3660.50%
202211.44-33.22%
202117.12-41.12%
202029.09-8.03%
201931.63-5.84%
201833.59-15.35%
201739.67-0.21%
201639.76-24.43%
201552.610.13%

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Average PE Ratio

How has 600867.SS PE Ratio performed in the past?

The current PE Ratio of Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-124.40

5-year avg

-65.40

10-year avg

-12.97

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) PE Ratio vs. Peers

How is 600867.SS’s PE Ratio compared to its peers?

Tonghua Dongbao Pharmaceutical Co., Ltd.’s PE Ratio is less than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (39.55), less than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (22.32), less than Apeloa Pharmaceutical Co.,Ltd (22.07), less than Yifan Pharmaceutical Co., Ltd. (36.04), greater than China Resources Double-Crane Pharmaceutical Co.,Ltd. (12.19), greater than Andon Health Co., Ltd. (8.97), less than Beijing Aosaikang Pharmaceutical Co., Ltd. (59.87), less than Anhui Anke Biotechnology (Group) Co., Ltd. (24.13), less than Qingdao Baheal Medical Inc. (23.25), less than Zhejiang CONBA Pharmaceutical Co.,Ltd. (16.96),

Build a custom stock screener for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonghua Dongbao Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tonghua Dongbao Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Tonghua Dongbao Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

What is the highest PE Ratio for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

What is the 3-year average PE Ratio for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

What is the 5-year average PE Ratio for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

How does the current PE Ratio for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) compare to its historical average?